Company overview

ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd., founded in June 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early-stage biopharmaceutical company dedicated to development and commercialization of novel cancer immunotherapeutics that reverse cancer cell-induced immune inhibition and actively eradicate cancer cells.

2Science & Technology
The company is mainly committed to the development and research of immunotherapy products for tumors. The researched and developed products include monoclonal antibodies against immunomodulatory targets and armed target-specific NK cells. immunomodulatory targets and armed target-specific NK cells
Science & Technology
The company is mainly committed to the development and research of immunotherapy products for tumors. The researched and developed products include monoclonal antibodies against immunomodulatory targets and armed target-specific NK cells.